Maintenance therapy promotes profound organ and haematologic response in light-chain amyloidosis patients not undergoing autologous stem cell transplantation
This study identified the clinical benefits of maintenance therapy in patients with AL who did not undergo ASCT in real-world practice.
Authors
- Wenjing Wang (ORCID: https://orcid.org/0000-0001-6025-9848)
- Chi Zhou (ORCID: https://orcid.org/0000-0002-9162-8594)
- Tianhong Xu (ORCID: https://orcid.org/0000-0001-8493-6874)
- Chenqi Yu
- Jing Li (ORCID: https://orcid.org/0000-0001-5127-9556)
- Peng Liu (ORCID: https://orcid.org/0000-0002-9639-6606)
- Pu Wang (ORCID: https://orcid.org/0000-0002-9185-1913)
- Yang Yang (ORCID: https://orcid.org/0000-0002-3007-6861)
Institutions
- Sun Yat-sen University (CN)
- Fudan University (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- YangPu Geriatric Hospital (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2024-10-20
- DOI
- https://doi.org/10.1080/07853890.2024.2418339
- Citations
- 2
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.47
Funders
- Natural Science Foundation of Shanghai
- Fudan University